Ontario-Israel Industrial Collaborative Research Projects

Convergent Medical Technologies

• CMTP Information Handbook
• CMTP Program Guidelines
• CMTP Expression of Interest Form

Background:

The Convergent Medical Technologies Program will directly invest in the growth of Ontario and Israeli companies that are in the convergent medical technology sector and interested in pursuing collaborative research and development (R&D) projects.

The program is jointly funded and delivered by the Canada-Israel Industrial Research & Development Foundation (CIIRDF), htx.ca - The Health Technologies Exchange (HTX), Ontario Centres of Excellence Inc. (OCE), and the Office of the Chief Scientist in Israel.

The program provides the opportunity for funding support of up to 50% of the cost of a joint R&D effort, provided it meets high standards of technological/scientific quality and commercial promise. At least 50% of the project costs in each country must be borne by the respective participants.

The program will fund joint R&D projects typically 24 months in duration undertaken by a company in Ontario in collaboration with a company in Israel. Collaborative projects involving academic research institutions in Ontario are encouraged and may be eligible for additional support. Typical project funding by the program will be in the range of CAD $300,000 to $500,000. Program funding to the companies is repayable from gross sales derived from the sale or other commercial exploitation of the product or process innovation resulting from the project.

The deadline for receipt of an Expression of Interest (EOI) is 25 January 2008, 17:00 local time.

All EOIs submitted will be reviewed by a panel of internal and external reviewers, and those selected by the panel will notified by 18 February 2008. Full proposals will be due by 31 March 2008.

All proposals submitted will be subject to peer review by external referees and ranked. A final decision on funding will be made by the middle of June 2008.

Eligibility

Companies from Ontario in collaboration with companies from Israel for R&D projects in the convergent medical technologies sector are eligible to apply. Collaborative projects involving academia are encouraged.

The program will facilitate partnership identification for companies interested in participating in the program that have not identified a counterpart partner in Ontario or Israel. To initiate partnership facilitation, the Partner Search Form set out in Appendix A of the EOI must be completed and submitted to Jennifer Woods, HTX, jwoods@htx.ca and Les Abelson, CIIRDF, lesabelson@ciirdf.ca. Identification of a partner may result in delay beyond the timelines of this Call for Proposal. Where such a delay is incurred, companies will be eligible to participate in subsequent Calls for Proposals.